Opportunity timeline
In plain English
NIH wants specialized blood products for its Clinical Center, including rare and multiple-antigen-negative red blood cells, AB plasma, cryoprecipitate, and single-donor platelets. Expected annual use is about 300–400 red blood cells, 50–100 units of AB plasma, and 100–200 platelets, with 24/7 support and nationwide sourcing. This is planned as a sole-source, 12-month IDIQ contract, but capable vendors may submit statements by September 20, 2026, at 9:00 AM, referencing POTS 26-008618.
About this opportunity
The National Institutes of Health (NIH), Clinical Center (CC), Office of Purchasing and Contracts, on behalf of the Department of Transfusion Medicine (DTM), Transfusion Services Laboratory (TSL), intends to award a sole-source Indefinite Delivery/Indefinite Quantity (IDIQ) contract to the National Blood Exchange (NBE), Association for the Advancement of Blood & Biotherapies (AABB) for the provision of specialized blood products, including rare blood types, required to support patient care within the NIH Clinical Center. The NIH Clinical Center is a 200-bed research hospital that provides care to patients participating in NIH research protocols. The Department of Transfusion Medicine…
Time remaining
Closes Sep 20, 2026
Related Opportunities

Blood Products & Immunohematology Reference Laboratory for the LIH

Cadavers

Costal Cartilage Allograft (BAMC, San Antonio, Texas)

National ALS Biorepository Research and Operational Support

VISN 7 Blood and Blood-Related Products
Bid details are gathered and summarized automatically. Please verify details at the original source.
Ref No.
BS-FF76DB

